Advertisement

Topics

Biotech Movers: Second-Quarter Results, Increased Outlook Send Horizon Pharma Shares Higher

11:19 EDT 7 Aug 2017 | Topix

Shares of Horizon Pharma plc rose 13.4% to $14.40 in premarket trading on Monday, Aug. 7, after the Dublin firm unveiled better-than-expected second-quarter results and raised its outlook. Horizon reported non-GAAP earnings per share of $0.41, compared with $0.56 in the year-ago period.

Original Article: Biotech Movers: Second-Quarter Results, Increased Outlook Send Horizon Pharma Shares Higher

NEXT ARTICLE

More From BioPortfolio on "Biotech Movers: Second-Quarter Results, Increased Outlook Send Horizon Pharma Shares Higher"

Quick Search
Advertisement